Below are showcased publications produced by NOAHE Members. If you are a NOAHE member and would like to have your publication featured on our website and on social media affiliated with the Network, please contact us at noahe@ihe.ca; Not a NOAHE member? Sign up here!

Please note: The publications listed on this page serve to showcase the work of our individual members only, and do not necessarily represent the views of the Network of Alberta Health Economists (NOAHE), NOAHE Members, and/or NOAHE funders.

Filter your search by clicking filters to the left.

Results for: Stephen Congly Philip Jacobs Christopher McCabe John Sproule Aidan Hollis

Logical Inconsistencies in the Health Years in Total and Equal Value of Life Years Gained

Factors Associated with Drug Shortages in Canada: A Retrospective Cohort Study.

Global clinical trial mobilization for COVID-19: higher, faster, stronger

Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus

Impact of isolation precautions on quality of life: a meta-analysis

Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit

Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting

Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT

How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?

Hard choices: Reflections from the tomb of the unknown patient

Early Initiation of Tumor Necrosis Factor Antagonist-Based Therapy for Patients With Crohn's Disease Reduces Costs Compared With Late Initiation

The Costs of Industry-Sponsored Drug Trials in Canada

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

The impact of pharmaceutical rebates on patients’ drug expenditures

Estimating the clinical cost of drug development for orphan versus non-orphan drugs

A Review of Measures of Aggregate Mental Health Costs in Canada

Cost Effectiveness of Early Insertion of Transjugular Intrahepatic Portosystemic Shunts for Recurrent Ascites

Cell-Free DNA–Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis

The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials

Bill C-30: who wins and who loses in Canada’s pharmaceutical patent battles?

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA-Prelim Trial

A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models

Show Drugs Work Before Selling Them

Determinants of Change in the Cost-effectiveness Threshold

Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk

The State of Health Economics in Alberta: A Review of Need, Capacity, and Action